Evidence map›Paper›PMID 30727757›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2019

Promoters to Study Vascular Smooth Muscle.

Raja Chakraborty, Fatima Zahra Saddouk, Ana Catarina Carrao, Diane S Krause, Daniel M Greif, Kathleen A Martin

Abstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Are RNA Therapies a Solid Foundation or a Frontier Yet to Be Conquered?International journal of molecular sciences · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. NovelPathology oncology research : POR · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raja ChakrabortyFrom the Department of Medicine, Section of Cardiovascular Medicine (R.C., F.Z.S., A.C.C., D.M.G., K.A.M.).
Fatima Zahra SaddoukFrom the Department of Medicine, Section of Cardiovascular Medicine (R.C., F.Z.S., A.C.C., D.M.G., K.A.M.).
Ana Catarina CarraoFrom the Department of Medicine, Section of Cardiovascular Medicine (R.C., F.Z.S., A.C.C., D.M.G., K.A.M.).
Diane S KrauseDepartments of Laboratory Medicine, Cell Biology, and Pathology (D.S.K.).
Daniel M GreifFrom the Department of Medicine, Section of Cardiovascular Medicine (R.C., F.Z.S., A.C.C., D.M.G., K.A.M.).
Kathleen A MartinFrom the Department of Medicine, Section of Cardiovascular Medicine (R.C., F.Z.S., A.C.C., D.M.G., K.A.M.).

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Novel targets of rapamycin and Akt in vascular smooth muscle cell differentiationR01HL091013 · NHLBI · YALE UNIVERSITY · PI MARTIN, KATHLEEN ANN · 2008 to 2017
$4.1M
Novel insights into intimal hyperplasia in cardiac allograft vasculopathyR01HL142090 · NHLBI · YALE UNIVERSITY · PI MARTIN, KATHLEEN ANN · 2018 to 2021
$2.4M
Coordinated regulation of vascular smooth muscle phenotype by p300, CBP, and TET2R01HL146101 · NHLBI · YALE UNIVERSITY · PI GALLAGHER, PATRICK G, MARTIN, KATHLEEN ANN · 2019 to 2022
$2.2M
Smooth muscle progenitors in vascular remodelingR01HL133016 · NHLBI · YALE UNIVERSITY · PI GREIF, DANIEL · 2016 to 2019
$1.7M
Pathological arterial muscularization and the role of integrinsR01HL125815 · NHLBI · YALE UNIVERSITY · PI GREIF, DANIEL · 2015 to 2018
$1.7M
Epigenetic control of vascular smooth muscle in cardiovascular diseaseR01HL119529 · NHLBI · YALE UNIVERSITY · PI MARTIN, KATHLEEN ANN · 2014 to 2017
$1.7M
Regulation of vascular smooth muscle cell plasticityR01HL118430 · NHLBI · YALE UNIVERSITY · PI MARTIN, KATHLEEN ANN · 2014 to 2017
$1.7M
Vascular disease pathogenesis: the interface of smooth muscle and immune cellsR01HL142674 · NHLBI · YALE UNIVERSITY · PI GREIF, DANIEL · 2018 to 2019
$1.1M
Aging and clonality in atherosclerosisR21AG062202 · NIA · YALE UNIVERSITY · PI FERNANDEZ HERNANDO, CARLOS, GREIF, DANIEL · 2019 to 2020
$461k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL091013NHLBI NIH HHS R01 HL118430NHLBI NIH HHS R01 HL119529NHLBI NIH HHS R01 HL125815NHLBI NIH HHS R01 HL133016NHLBI NIH HHS R01 HL142090NHLBI NIH HHS R01 HL142674NHLBI NIH HHS R01 HL146101NIA NIH HHS R21 AG062202
6 · The paper itself

Abstract

Smooth muscle cells (SMCs) are a critical component of blood vessel walls that provide structural support, regulate vascular tone, and allow for vascular remodeling. These cells also exhibit a remarkable plasticity that contributes to vascular growth and repair but also to cardiovascular pathologies, including atherosclerosis, intimal hyperplasia and restenosis, aneurysm, and transplant vasculopathy. Mouse models have been an important tool for the study of SMC functions. The development of smooth muscle-expressing Cre-driver lines has allowed for exciting discoveries, including recent advances revealing the diversity of phenotypes derived from mature SMC transdifferentiation in vivo using inducible CreER

Indexed as

Promoter Regions, GeneticActinsAnimalsCell LineCell LineageCell TransdifferentiationGene Expression RegulationGene Knockout TechniquesGene TargetingHumansMiceMicrofilament ProteinsMuscle ProteinsMuscle, Smooth, VascularMyocytes, Smooth MuscleMyofibroblastsActa2 protein, mouseActinsMicrofilament ProteinsMuscle Proteinsmyosin 11, mouseMyosin Heavy ChainsRecombinant Fusion ProteinsTagln protein, mouseatherosclerosisgene expressionmice, transgenicmuscle, smoothmyeloid cellsneointima

Identifiers

PMID30727757
PMCPMC6527360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.